You are here:
Information Letter on acitretin and teratogenicity: Extension of the contraception period and the prohibition of blood donation after end of therapy
2016.11.08
Active substance: acitretin
In an Information Letter, the companies Dermapharm and Puren Pharma point out the extension of the contraception period and the prohibition of blood donation up to three years after discontinuation of therapy with acitretin.
Download DHPC / Information letter , Download_VeroeffentlichtAm_EN